SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-24-036149
Filing Date
2024-08-08
Accepted
2024-08-08 16:14:52
Documents
78
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q gthx-20240630.htm   iXBRL 10-Q 993291
2 EX-10.5 gthx-20240630xex105.htm EX-10.5 20311
3 EX-10.6 gthx-20240630xex106.htm EX-10.6 20217
4 EX-10.7 gthx-20240630xex107.htm EX-10.7 20228
5 EX-31.1 gthx-20240630xex311.htm EX-31.1 10849
6 EX-31.2 gthx-20240630xex312.htm EX-31.2 10914
7 EX-32.1 gthx-20240630xex321.htm EX-32.1 5620
8 EX-32.2 gthx-20240630xex322.htm EX-32.2 5684
14 gthx-20240630_g1.jpg GRAPHIC 8623
  Complete submission text file 0001628280-24-036149.txt   6176410

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gthx-20240630.xsd EX-101.SCH 45267
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT gthx-20240630_cal.xml EX-101.CAL 53255
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT gthx-20240630_def.xml EX-101.DEF 229167
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT gthx-20240630_lab.xml EX-101.LAB 602616
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gthx-20240630_pre.xml EX-101.PRE 434904
80 EXTRACTED XBRL INSTANCE DOCUMENT gthx-20240630_htm.xml XML 696969
Mailing Address 700 PARK OFFICES DRIVE SUITE 200 RESEARCH TRIANGLE PARK NC 27709
Business Address 700 PARK OFFICES DRIVE SUITE 200 RESEARCH TRIANGLE PARK NC 27709 919-213-9835
G1 Therapeutics, Inc. (Filer) CIK: 0001560241 (see all company filings)

IRS No.: 263648180 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38096 | Film No.: 241188529
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)